United States· US:67225-5015_457c07a5-ae64-9cf7-e063-6294a90ac094
AGE20S SIGNATURE ESSENCE PACT INTENSE COVER 17N
A medicinal product containing octocrylene; octinoxate; titanium dioxide, registered in United States by Aekyung Industrial Co., Ltd..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OCTOCRYLENE; OCTINOXATE; TITANIUM DIOXIDE
- Manufacturer
- Aekyung Industrial Co., Ltd.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1167225-5015-2
- ndc1167225501522 CASE in 1 PACKAGE (67225-5015-2) / 14 g in 1 CASE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/db850d68-fa53-4bd6-8960-90d4285b0089 GET /v1/drugs/db850d68-fa53-4bd6-8960-90d4285b0089?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": ".42; .91; .7168",
"substance": "OCTOCRYLENE; OCTINOXATE; TITANIUM DIOXIDE",
"productndc": "67225-5015",
"dosage_form": "CREAM",
"dea_schedule": null,
"strength_unit": "g/14g; g/14g; g/14g",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about octocrylene; octinoxate; titanium dioxide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.